Login / Signup

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients.

Gian Maria ZaccariaLuca BertaminiMaria Teresa PetrucciMassimo OffidaniPaolo CorradiniAndrea CapraAlessandra RomanoAnna Marina LiberatiDonato ManninaPaolo de FabritiisNicola CascavillaMarina RuggeriRoberto MinaFrancesca PatriarcaGiulia BenevoloAngelo BelottiGianluca GaidanoArnon NaglerRoman HájekAndrew SpencerPieter SonneveldPellegrino MustoMario BoccadoroFrancesca Gay
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
On the basis of simple, widely available baseline features, the S-ERMM and DS-ERMM properly identified patients with different risks of ER and survival outcomes.
Keyphrases
  • newly diagnosed
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • clinical trial
  • free survival